Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1862 2
1895 1
1898 2
1901 2
1922 1
1928 1
1933 1
1946 4
1947 6
1948 4
1949 2
1950 1
1951 2
1952 5
1953 3
1954 4
1955 2
1956 1
1957 4
1958 2
1959 6
1960 2
1961 2
1963 1
1964 1
1965 1
1966 1
1967 5
1968 1
1969 1
1970 3
1971 3
1972 4
1973 4
1974 1
1975 5
1976 7
1977 10
1978 7
1979 4
1980 3
1981 7
1982 13
1983 16
1984 17
1985 16
1986 20
1987 24
1988 14
1989 26
1990 12
1991 22
1992 16
1993 16
1994 18
1995 20
1996 18
1997 16
1998 15
1999 32
2000 9
2001 9
2002 11
2003 16
2004 13
2005 15
2006 17
2007 18
2008 39
2009 32
2010 32
2011 29
2012 38
2013 41
2014 34
2015 26
2016 20
2017 31
2018 49
2019 47
2020 56
2021 62
2022 59
2023 55
2024 48
2025 51

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,229 results

Results by year

Filters applied: . Clear all
Page 1
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.
Ahmed N, Brawley VS, Hegde M, Robertson C, Ghazi A, Gerken C, Liu E, Dakhova O, Ashoori A, Corder A, Gray T, Wu MF, Liu H, Hicks J, Rainusso N, Dotti G, Mei Z, Grilley B, Gee A, Rooney CM, Brenner MK, Heslop HE, Wels WS, Wang LL, Anderson P, Gottschalk S. Ahmed N, et al. Among authors: gray t. J Clin Oncol. 2015 May 20;33(15):1688-96. doi: 10.1200/JCO.2014.58.0225. Epub 2015 Mar 23. J Clin Oncol. 2015. PMID: 25800760 Free PMC article. Clinical Trial.
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S. Ahmed N, et al. Among authors: gray tl. JAMA Oncol. 2017 Aug 1;3(8):1094-1101. doi: 10.1001/jamaoncol.2017.0184. JAMA Oncol. 2017. PMID: 28426845 Free PMC article. Clinical Trial.
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Tong SYC, Lye DC, Yahav D, Sud A, Robinson JO, Nelson J, Archuleta S, Roberts MA, Cass A, Paterson DL, Foo H, Paul M, Guy SD, Tramontana AR, Walls GB, McBride S, Bak N, Ghosh N, Rogers BA, Ralph AP, Davies J, Ferguson PE, Dotel R, McKew GL, Gray TJ, Holmes NE, Smith S, Warner MS, Kalimuddin S, Young BE, Runnegar N, Andresen DN, Anagnostou NA, Johnson SA, Chatfield MD, Cheng AC, Fowler VG Jr, Howden BP, Meagher N, Price DJ, van Hal SJ, O'Sullivan MVN, Davis JS; Australasian Society for Infectious Diseases Clinical Research Network. Tong SYC, et al. Among authors: gray tj. JAMA. 2020 Feb 11;323(6):527-537. doi: 10.1001/jama.2020.0103. JAMA. 2020. PMID: 32044943 Free PMC article. Clinical Trial.
Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study.
Meric-Bernstam F, Beeram M, Hamilton E, Oh DY, Hanna DL, Kang YK, Elimova E, Chaves J, Goodwin R, Lee J, Nabell L, Rha SY, Mayordomo J, El-Khoueiry A, Pant S, Raghav K, Kim JW, Patnaik A, Gray T, Davies R, Ozog MA, Woolery J, Lee KW. Meric-Bernstam F, et al. Among authors: gray t. Lancet Oncol. 2022 Dec;23(12):1558-1570. doi: 10.1016/S1470-2045(22)00621-0. Epub 2022 Nov 16. Lancet Oncol. 2022. PMID: 36400106 Clinical Trial.
Three-Electron Nickel(I)/Nickel(0) Half-Bond.
Dodd NA, Cao Y, Bacsa J, Towles EC, Gray TG, Sadighi JP. Dodd NA, et al. Among authors: gray tg. Inorg Chem. 2022 Oct 17;61(41):16317-16324. doi: 10.1021/acs.inorgchem.2c02291. Epub 2022 Sep 30. Inorg Chem. 2022. PMID: 36179078
Osteochondral Talar Shoulder Lesion Treatment Options.
Millonig KJ, Gray TR. Millonig KJ, et al. Among authors: gray tr. Clin Podiatr Med Surg. 2025 Apr;42(2):259-274. doi: 10.1016/j.cpm.2024.10.008. Epub 2024 Nov 30. Clin Podiatr Med Surg. 2025. PMID: 39988391 Review.
Review of fluvoxamine safety database.
Wagner W, Plekkenpol B, Gray TE, Vlaskamp H, Essers H. Wagner W, et al. Among authors: gray te. Drugs. 1992;43 Suppl 2:48-53; discussion 53-4. doi: 10.2165/00003495-199200432-00008. Drugs. 1992. PMID: 1378374 Review.
1,229 results